Literature DB >> 18023272

Heterologous expression and biochemical characterization of soluble human xylosyltransferase II.

Javier Carrera Casanova1, Joachim Kuhn, Knut Kleesiek, Christian Götting.   

Abstract

Human xylosyltransferase II (EC 2.4.2.26, XT-II) represents an isoform of xylosyltransferase I (XT-I). Recently, we and others provided first evidence that XT-II is capable of initiating the biosynthesis of glycosaminoglycan chains in proteoglycans. Here, a soluble form of human XT-II was expressed in the yeast Pichia pastoris and the substrate specificity for various acceptors was investigated, pointing to a modified bikunin peptide to be the optimal XT-II acceptor (K(M)=1.9 microM). Furthermore, biochemical characterization of XT-II showed that this enzyme was strongly inhibited by nucleotides and glycosaminoglycans. Its temperature optimum, stability, and ion dependency were further examined, demonstrating necessity for Mg(2+) or Mn(2+) ions for its enzymatic activity. Our data show for the first time that XT-I and XT-II are xylosyltransferases with similar but not identical properties, pointing to their potential role in modulating the cellular proteoglycan pool.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023272     DOI: 10.1016/j.bbrc.2007.10.206

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  The Impact of Inflammatory Stimuli on Xylosyltransferase-I Regulation in Primary Human Dermal Fibroblasts.

Authors:  Thanh-Diep Ly; Christopher Lindenkamp; Eva Kara; Vanessa Schmidt; Anika Kleine; Bastian Fischer; Doris Hendig; Cornelius Knabbe; Isabel Faust-Hinse
Journal:  Biomedicines       Date:  2022-06-19

2.  Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.

Authors:  Eduard Condac; George L Dale; Diane Bender-Neal; Beatrix Ferencz; Rheal Towner; Myron E Hinsdale
Journal:  Glycobiology       Date:  2009-04-23       Impact factor: 4.313

3.  A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection.

Authors:  Amber M Riblett; Vincent A Blomen; Lucas T Jae; Louis A Altamura; Robert W Doms; Thijn R Brummelkamp; Jason A Wojcechowskyj
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

4.  Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.

Authors:  Joachim Kuhn; Christian Götting; Brendan J Beahm; Carolyn R Bertozzi; Isabel Faust; Patricia Kuzaj; Cornelius Knabbe; Doris Hendig
Journal:  Biochem Biophys Res Commun       Date:  2015-03-03       Impact factor: 3.575

Review 5.  Recent advances on glycosyltransferases involved in the biosynthesis of the proteoglycan linkage region.

Authors:  Jia Gao; Xuefei Huang
Journal:  Adv Carbohydr Chem Biochem       Date:  2021-11-24       Impact factor: 3.714

6.  Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.

Authors:  William M Schneider; Joseph M Luna; H-Heinrich Hoffmann; Francisco J Sánchez-Rivera; Andrew A Leal; Alison W Ashbrook; Jérémie Le Pen; Inna Ricardo-Lax; Eleftherios Michailidis; Avery Peace; Ansgar F Stenzel; Scott W Lowe; Margaret R MacDonald; Charles M Rice; John T Poirier
Journal:  Cell       Date:  2020-12-09       Impact factor: 66.850

7.  Human xylosyltransferases--mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapy.

Authors:  Isabel Faust; Philipp Traut; Frank Nolting; Jan Petschallies; Elena Neumann; Elke Kunisch; Joachim Kuhn; Cornelius Knabbe; Doris Hendig
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

8.  Identification of Putative Non-Substrate-Based XT-I Inhibitors by Natural Product Library Screening.

Authors:  Thanh-Diep Ly; Anika Kleine; Bastian Fischer; Vanessa Schmidt; Doris Hendig; Joachim Kuhn; Cornelius Knabbe; Isabel Faust
Journal:  Biomolecules       Date:  2020-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.